Categories AlphaGraphs, Earnings, Health Care

CVS Health Corporation (CVS) Earnings: 3Q22 Key Numbers

CVS Health Corporation (NYSE: CVS) reported third quarter 2022 earnings results.

Total revenues increased 10% year-over-year to $81.2 billion.

Net loss attributable to CVS Health was $3.4 billion, or $2.60 per share, compared to net income of $1.6 billion, or $1.20 per share, in the year-ago quarter. Adjusted EPS amounted to $2.09.

For the full year of 2022, CVS expects adjusted EPS to be $8.55-8.65.

In September, the company entered into an agreement to acquire Signify Health, Inc. for approx. $8 billion. The transaction is expected to close in the first half of 2023.

Prior performance

CVS Health Q2 2022 Earnings Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line

Macy’s (M): A few points to consider if you have an eye on this retailer

Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent

Add Comment
Viewing Highlight